Newscenter Media News
Neimeth International Pharmaceuticals Plc grew its post-tax profit by 144 per cent to N198.2m in the first half of 2024. Gross profit rose by 211 per cent to N933.9m, from N300.6m in H1 2023, attributed to production processes and economies of scale. The company’s turnover for the half-year ended June 30, surged by 73 per